Active Drug-Using Women Use Female-Initiated Barrier Methods to Reduce HIV/STI Risk: Results from a Randomized Trial
ISRN Addiction · 2013
DOI: 10.1155/2013/768258 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift ISRN Addiction, 2013. Verfasst von Erica Gollub und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8th Street, Miami, FL…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: FIC NIH HHS, NIMHD NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
Background
We tested an original, woman-focused intervention, based on body empowerment, and female-initiated barrier methods, including the female condom (FC) and cervical barriers.
Methods
Eligible women were >= 18 years of age, HIV seronegative, and active drug users, reporting 30% or greater unprotected sex acts. Both controls (C) and intervention (I) participants received enhanced HIV/STI harm reduction counseling. I participants underwent 5 additional weekly group sessions. We compared change in frequency of unprotected vaginal intercourse across arms at 12 months.
Results
Among 198 enrolled women, over 95% completed followup. Two-thirds were African-American; most of them used crack, had a primary partner, and reported sex exchange. In paired t -tests from baseline to followup, the frequency of unprotected vaginal sex dropped significantly for I (primary , nonprimary ) and C (primary , nonprimary ) arms with all partners. The difference in change across arms was of borderline significance for primary partner (); no difference was seen for nonprimary partner (). Use of male condom and FC increased with both partner types over time, but more consistently among I women.
Conclusion
The “value-added” impact of the intervention was observed mainly with primary partners. Body knowledge with routine FC counseling should be incorporated into interventions for drug-using women.
Autor:innen und Institutionen
- Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8th Street, Miami, FL 33199, USA.
- Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, 11200 SW 8th Street, Miami, FL 33199, USA ; Center for Research on U.S. Latino HIV/AIDS and Drug Abu…
- Drexel Hill, PA 19026, USA.
- Center for Studies on Addiction, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Regional West Medical Center, Scottsbluff, NE 69361, USA.
- HIV/AIDS Prevention Research Division, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA.
ORCID-Profile: Tamara Boney
Förderung
- FIC NIH HHS
- NIMHD NIH HHS
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Gollub, E., Cyrus-Cameron, E., Armstrong, K., Boney, T., Mercer, D., Fiore, D., & Chhatre, S. (2013). Active Drug-Using Women Use Female-Initiated Barrier Methods to Reduce HIV/STI Risk: Results from a Randomized Trial. ISRN Addiction. https://doi.org/10.1155/2013/768258
Vancouver
Gollub E, Cyrus-Cameron E, Armstrong K, Boney T, Mercer D, Fiore D, et al. Active Drug-Using Women Use Female-Initiated Barrier Methods to Reduce HIV/STI Risk: Results from a Randomized Trial. ISRN Addiction. 2013. doi:10.1155/2013/768258
BibTeX
@article{Gollub2013,
author = {Gollub, Erica and Cyrus-Cameron, Elena and Armstrong, Kay and Boney, Tamara and Mercer, Delinda and Fiore, Danielle and Chhatre, Sumedha},
title = {Active Drug-Using Women Use Female-Initiated Barrier Methods to Reduce HIV/STI Risk: Results from a Randomized Trial},
journal = {ISRN Addiction},
year = {2013},
doi = {10.1155/2013/768258}
}
EUVIMED